NCT01223625View on ClinicalTrials.gov

Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2010

Conditions

Endothelial DysfunctionAtherosclerosis

Interventions

DRUG

Rosuvastatin 5mg/day

DRUG

Rosuvastatin 40mg/day

Trial Locations (1)

5000

Department of Cardiology, Odense University Hospital, Odense

All Listed Sponsors

lead

Odense University Hospital

OTHER

NCT01223625 - Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function | Biotech Hunter | Biotech Hunter